This is why reading the vial label before every single injection is non-negotiable
Importantly, the observed rise in the relative risk of new thyroid cancer diagnoses was limited to the first year after GLP-1RA initiation
The drug is injected once a week, and patients should expect gradual weight loss over time
Theyll likely want to discuss how well youve tolerated semaglutide, your weight loss progress, and whether youre meeting your health goals
Tirzepatide is a cutting-edge injectable medication designed to support weight loss by targeting two key hormone receptors in the bodyGLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide)
For liraglutide, 21.8% of patients doubled their weight loss, 15.9% lost some additional weight, and 14.2% maintained their loss, with 51.9% in total maintaining or losing more weight